Cargando…
Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604568/ https://www.ncbi.nlm.nih.gov/pubmed/34808242 http://dx.doi.org/10.1016/j.jinf.2021.11.013 |
| _version_ | 1784601990452477952 |
|---|---|
| author | Luo, Lili Luo, Ting Du, Mengyi Mei, Heng Hu, Yu |
| author_facet | Luo, Lili Luo, Ting Du, Mengyi Mei, Heng Hu, Yu |
| author_sort | Luo, Lili |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8604568 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86045682021-11-22 Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis Luo, Lili Luo, Ting Du, Mengyi Mei, Heng Hu, Yu J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-03 2021-11-20 /pmc/articles/PMC8604568/ /pubmed/34808242 http://dx.doi.org/10.1016/j.jinf.2021.11.013 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Luo, Lili Luo, Ting Du, Mengyi Mei, Heng Hu, Yu Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis |
| title | Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis |
| title_full | Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis |
| title_fullStr | Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis |
| title_full_unstemmed | Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis |
| title_short | Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis |
| title_sort | efficacy and safety of tocilizumab in hospitalized covid-19 patients: a systematic review and meta-analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604568/ https://www.ncbi.nlm.nih.gov/pubmed/34808242 http://dx.doi.org/10.1016/j.jinf.2021.11.013 |
| work_keys_str_mv | AT luolili efficacyandsafetyoftocilizumabinhospitalizedcovid19patientsasystematicreviewandmetaanalysis AT luoting efficacyandsafetyoftocilizumabinhospitalizedcovid19patientsasystematicreviewandmetaanalysis AT dumengyi efficacyandsafetyoftocilizumabinhospitalizedcovid19patientsasystematicreviewandmetaanalysis AT meiheng efficacyandsafetyoftocilizumabinhospitalizedcovid19patientsasystematicreviewandmetaanalysis AT huyu efficacyandsafetyoftocilizumabinhospitalizedcovid19patientsasystematicreviewandmetaanalysis |